Bharat Immunologicals Financial Statements Trends

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 22.45  0.05  0.22%

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.

Current Valuation Analysis

Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Bharat Immunologicals 
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
 = 
862.5 M

About Current Valuation

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has Current Valuation of 862.5 M. This is much higher than that of the sector, and significantly higher than that of Current Valuation industry, The Current Valuation for all stocks is over 1000% lower than the firm.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in gross profit category among related companies. It is rated below average in ebitda category among related companies .

Peer Comparison

Bharat Immunologicals Current Ratio Comparison
Bharat Immunologicals is currently under evaluation in current ratio category among related companies.

Did you try this?

Run Transaction History Now
   

Transaction History

View history of all your transactions and understand their impact on performance
Hide  View All  Next  Launch Transaction History

Fundamental Indicators

Current Bharat Immunologicals financial ratios